A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid Tumours

This trial is no longer accepting participants. To get information / assistance in finding a clinical trial that is right for you, please call Cancer AnwerLine at 800-865-1125.